mechanism of action glp-1 agonist of agonists – My Endo Consult Frontiers | GLP-1 Receptor Agonists:
Description
In the LEAD series of studies, clinical data demonstrated that treatment with liraglutide for 26 weeks can reduce SBP [4]
In addition, glutamate and alanine in positions 21 and 24 respectively were reversed, and a glycine residue at position 29 was replaced by asparagine
DA, dopaminergic
Ive really only mentioned the biggest con of GLP-1 agonists which is a potential risk of thyroid cancer but there are others to consider such as muscle loss as well
doi: 10.1002/jcph.386 123 WangJHuangJLiWTangSSunJZhangXet al
Therefore, expanding the range of available pharmacotherapies is essential to better support individuals with AUD [9]
